Chickenpox: Clinical Trials

21 trials for Chickenpox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 221Completed 21

Follow Chickenpox: new trials by email Literature Review of Chickenpox trials Research Report on Chickenpox

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS vaccine, Investigational M(L)M(L)R(L)V(L)NS vaccine - Measles; Mumps; Rubella; Chickenpox, Measles
Phase 2CompletedGlaxoSmithKline8012022-12-142025-06-22
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
Investigational varicella vaccine low potency, Investigational varicella vaccine medium potency, Investigational varicella vaccine high potency - Chickenpox
Phase 2CompletedGlaxoSmithKline8002022-02-032025-02-28
Systems Biology of Zoster Vaccine
Shingrix® - Zoster, Zoster Varicella
Phase 2CompletedEmory University382019-11-142024-07-30
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
NBP608, Varivax - Varicella
Phase 2CompletedSK Chemicals Co., Ltd.1522016-05-012017-04-14
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine), GSK Biologicals' 208136, new formulation - Measles, Varicella
Phase 2CompletedGlaxoSmithKline5012009-06-032019-11-15
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
ZOSTAVAX, Placebo - Herpes Zoster, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3952009-04-292021-11-04
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Herpes zoster vaccine GSK1437173A, Placebo - Herpes Zoster
Phase 2CompletedGlaxoSmithKline4102009-01-122019-06-26
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
Priorix-Tetra™ (MMRV vaccine 208136), ProQuad®, Havrix® - Varicella, Rubella
Phase 2CompletedGlaxoSmithKline18512007-11-202018-10-09
Study of Two Formulations of GSK Biologicals' Varicella Vaccine
Varilrix (inactivated varicella vaccine) - Varicella
Phase 2CompletedGlaxoSmithKline2442007-11-012018-06-08
Month 30 & 42 Extension Studies of CRD-004 Primary Study
Blood sampling for assay of persistence of immunogenicity - Herpes Zoster
Phase 2CompletedGlaxoSmithKline342007-06-252019-06-26
An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).
placebo, carisbamate - Postherpetic Neuralgia, Neuralgia
Phase 2CompletedSK Life Science, Inc.912007-03-012018-05-01
Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects
Herpes Zoster vaccine GSK1437173A Low Dose, Herpes Zoster vaccine GSK1437173A Medium Dose, Herpes Zoster vaccine GSK1437173A High Dose - Herpes Zoster
Phase 2CompletedGlaxoSmithKline7152007-02-142019-03-15
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
MeMuRu-OKA (study vac), MMR, Varicella vacc (control) - Mumps, Rubella
Phase 2CompletedGlaxoSmithKline4002006-04-012016-10-07
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
MeMuRu-OKA (study vacc), MMR, Varicella vacc (control) - Varicella, Rubella
Phase 2CompletedGlaxoSmithKline4462006-03-012016-10-07
Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).
VarilrixTM - Varicella
Phase 2CompletedGlaxoSmithKline452003-09-082018-11-08
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
Capsaicin Patch - Neuralgia, Pain
Phase 2CompletedNeurogesX422002-03-012006-02-07
Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)
measles, mumps, and rubella virus vaccine live, Comparator: Measles, Mumps, and Rubella Virus Vaccine Live - Measles, Mumps
Phase 2CompletedMerck Sharp & Dohme LLC12102001-12-012017-03-15
Shingles: Immune Effects of Tai Chi
Tai Chi Chih - Aging, Herpes Zoster
Phase 2CompletedNational Institute on Aging (NIA)1402001-07-012009-12-11
ProQuad Dose Selection Study (V221-011)(COMPLETED)
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, Comparator: M-M-R II, Comparator: PUVV - Measles, Mumps
Phase 2CompletedMerck Sharp & Dohme LLC15511999-04-012015-04-10
Tai Chi Chih and Varicella Zoster Immunity
Tai chi chih - Varicella
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)702006-08-18

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Herpes Zoster (9)  ·  Measles (7)  ·  Mumps (7)  ·  Rubella (7)  ·  HIV Infections (2)  ·  Neuralgia (2)  ·  Neuralgia, Postherpetic (2)  ·  AIDS-Related Complex (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Blister (1)  ·  Depression (1)  ·  Exanthema (1)  ·  Hyperalgesia (1)  ·  Pain (1)

Broader conditions

DNA Virus Infections (21)  ·  Herpesviridae Infections (21)  ·  Infections (21)  ·  Varicella Zoster Virus Infection (21)  ·  Virus Diseases (21)  ·  RNA Virus Infections (9)  ·  Mononegavirales Infections (7)  ·  Morbillivirus Infections (7)  ·  Mouth Diseases (7)  ·  Paramyxoviridae Infections (7)  ·  Parotid Diseases (7)  ·  Parotitis (7)  ·  Rubivirus Infections (7)  ·  Rubulavirus Infections (7)  ·  Salivary Gland Diseases (7)

Interventions

measles, mumps, rubella, varicella vaccine (3)  ·  Hepatitis A Vaccines (2)  ·  Measles-Mumps-Rubella Vaccine (2)  ·  Acyclovir (1)  ·  Blood Specimen Collection (1)  ·  Chickenpox Vaccine (1)  ·  Heptavalent Pneumococcal Conjugate Vaccine (1)  ·  Herpes Zoster Vaccine (1)  ·  Rubella Vaccine (1)  ·  S-2-O-carbamoyl-1-o-chlorophenyl-ethanol (1)  ·  Sodium Chloride (1)  ·  sorivudine (1)

Sponsors

GlaxoSmithKline (11)  ·  Merck Sharp & Dohme LLC (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Emory University (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National Institute on Aging (NIA) (1)  ·  NeurogesX (1)  ·  SK Chemicals Co., Ltd. (1)  ·  SK Life Science, Inc. (1)

Countries

United States (10)  ·  Czechia (3)  ·  Taiwan (3)  ·  Germany (2)  ·  Italy (2)  ·  Puerto Rico (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Colombia (1)  ·  Estonia (1)  ·  France (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Netherlands (1)

Top investigators

Constance A. Benson, MD (1)  ·  Crumpacker C (1)  ·  Jeffrey L. Lennox, MD (1)  ·  John A Jermano (1)  ·  Michael R. Irwin, MD (1)  ·  Nadine Rouphael, MD (1)

Results publications

PMID 16094218, PMID 18652095, PMID 21934474, PMID 22872734, PMID 25272081, PMID 26762528, PMID 29461919, PMID 29590326, PMID 30975567, PMID 41825190

NIH funding

2008 (1), R01AG018367 (1), U19AI090023 (1)